Stimulant safe supply: a potential opportunity to respond to the overdose epidemic
Tóm tắt
Từ khóa
Tài liệu tham khảo
United Nations Office on Drugs and Crime. Treatment of stimulant use disorders: current practices and promising perspectives. Geneva: United Nations Office on Drugs and Crime; 2019.
United Nations Office on Drugs and Crime. World drug report 2018. Vienna, AT: United Nations publication; June 2018.
Kariisa MSL, Wilson N, Seth P, Hoots B. Drug overdose deaths involving cocaine and psychostimulants with abuse potential — United States, 2003–2017. MMWR Morb Mortal Wkly Rep. 2019;68:388–95.
Centres for Disease Control and Prevention. Overdose deaths involving opioids, cocaine, and psychostimulants — United States, 2015–2016 2018 [Available from: https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a1.htm#T1_down. Accessed 24 May 2019.
BC Coroners Service. Fentanyl-detected illicit drug overdose deaths: January 1, 2012 to March 31, 2019. BC Coroners Service; 2019.
Ahmad FB, Escobedo LA, Rossen LM, Spencer MR, Warner M, Sutton P. Provisional drug overdose death counts National Center for Health Statistics: National Center for Health Statistics; 2019 [Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed 23 June 2019.
United States Drug Enforcement Administration. 2018 National drug threat assessment. October 2018.
Ministry of Public Safety and Solicitor General. Illicit drug overdose deaths in BC: findings of coroners’ investigations. BC Coroners Service; 2018.
BC Coroners Service. Illicit drug overdose deaths in BC January 1, 2008 - March 31, 2019. BC Coroners Service; 2019.
Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242–5.
Rhodes T, Wagner K, Strathdee SA, Shannon K, Davidson P, Bourgois P. Structural violence and structural vulnerability within the risk environment: theoretical and methodological perspectives for a social epidemiology of HIV risk among injection drug users and sex workers. In: O’Campo P, Dunn JR, editors. Rethinking social epidemiology: towards a science of change. Dordrecht: Springer Netherlands; 2012. p. 205–30.
Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants — United States, 2015-2016. Morb Mortal Wkly Rep. 2018;67(12):349–58.
Shannon K, Strathdee S, Shoveller J, Zhang R, Montaner J, Tyndall M. Crystal methamphetamine use among female street-based sex workers: moving beyond individual-focused interventions. Drug and Alcohol Dependence. 2011;113(1):76–81.
Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2018.
Cumming C, Troeung L, Young JT, Kelty E, Preen DB. Barriers to accessing methamphetamine treatment: a systematic review and meta-analysis. Drug Alcohol Depend. 2016;168:263–73.
Wechsberg WM, Zule WA, Riehman KS, Luseno WK, Lam WK. African-American crack abusers and drug treatment initiation: barriers and effects of a pretreatment intervention. Subst Abuse Treat Prev Policy. 2007;2(1):10.
Damon W, Small W, Anderson S, Maher L, Wood E, Kerr T, et al. 'Crisis' and 'everyday' initiators: a qualitative study of coercion and agency in the context of methadone maintenance treatment initiation. Drug Alcohol Rev. 2017;36(2):253–60.
Fischer B, Blanken P, Da Silveira D, Gallassi A, Goldner EM, Rehm J, et al. Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies. Int J Drug Policy. 2015;26(4):352–63.
Substance Abuse and Mental Health Services Administration. Data on substance abuse treatment facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.
Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, et al. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction. 2014;109(9):1426–36.
Harada T, Tsutomi H, Mori R, Wilson DB. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders. Cochrane Database of Systematic Reviews. 2018(12).
Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46–53.
Kennedy MC, Scheim A, Rachlis B, Mitra S, Bardwell G, Rourke S, et al. Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city. Drug Alcohol Depend. 2018;185:248–52.
Bardwell G, Boyd J, Arredondo J, McNeil R, Kerr T. Trusting the source: the potential role of drug dealers in reducing drug-related harms via drug checking. Drug Alcohol Depend. 2019;198:1–6.
Bourque S, Pijl EM, Mason E, Manning J, Motz T. Supervised inhalation is an important part of supervised consumption services. Can J Public Health. 2019;110(2):210–5.
Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Harrison S, et al. Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods. J Subst Abuse Treat. 2019;101:50–4.
Fairgrieve C, Fairbairn N, Samet JH, Nolan S. Nontraditional alcohol and opioid agonist treatment interventions. Med Clin North Am. 2018;102(4):683–96.
Rezaei F, Emami M, Zahed S, Morabbi M-J, Farahzadi M, Akhondzadeh S. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial. DARU. 2015;23(1):2.
Dürsteler-MacFarland KM, Farronato NS, Strasser J, Boss J, Kuntze MF, Petitjean SA, et al. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription. J Clin Psychopharmacol. 2013;33(1):104–8.
Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, et al. Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit/hyperactivity disorder and cocaine use disorder: a randomized clinical trial extended-release mixed amphetamine salts for adhd/cocaine use disorderextended-release mixed amphetamine salts for adhd/cocaine use disorder. JAMA Psychiatry. 2015;72(6):593–602.
Pérez-Mañá C, Castells X, Torrens M, Capellà D, Farre M. Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database Syst Rev. 2013;9.
Castells X, Cunill R, Pérez-Mañá C, Vidal X, Capellà D. Psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev. 2016;9.
Armstrong G, Kermode M, Sharma C, Langkham B, Crofts N. Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action. Harm Reduction J. 2010;7(1):29.
MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.
Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.
Oviedo-Joekes E, Guh D, Brissette S, Marchand K, MacDonald S, Lock K, et al. Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial hydromorphone vs diacetylmorphine for long-term opioid dependence. JAMA Psychiatry. 2016;73(5):447–55.
Darke S, Kaye S, Duflou J. Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study. Addiction. 2017;112(12):2191–201.
Canadian Association of People who Use Drugs. Safe supply concept document. 2019.
Davidson PJ, Lopez AM, Kral AH. Using drugs in un/safe spaces: impact of perceived illegality on an underground supervised injecting facility in the United States. Int J Drug Policy. 2018;53:37–44.
Karazivan P, Dumez V, Flora L, Pomey MP, Del Grande C, Ghadiri DP, et al. The patient-as-partner approach in health care: a conceptual framework for a necessary transition. Acad Med. 2015;90(4):437–41.